BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24265133)

  • 1. Identification of amino acid residues in the ligand-binding domain of the aryl hydrocarbon receptor causing the species-specific response to omeprazole: possible determinants for binding putative endogenous ligands.
    Shiizaki K; Ohsako S; Kawanishi M; Yagi T
    Mol Pharmacol; 2014 Feb; 85(2):279-89. PubMed ID: 24265133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial metabolites of omeprazole activate murine aryl hydrocarbon receptor in vitro and in vivo.
    Shiizaki K; Kawanishi M; Yagi T
    Drug Metab Dispos; 2014 Oct; 42(10):1690-7. PubMed ID: 25061160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different structural requirements of the ligand binding domain of the aryl hydrocarbon receptor for high- and low-affinity ligand binding and receptor activation.
    Backlund M; Ingelman-Sundberg M
    Mol Pharmacol; 2004 Feb; 65(2):416-25. PubMed ID: 14742684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transduction-mediated activation of the aryl hydrocarbon receptor in rat hepatoma H4IIE cells.
    Backlund M; Johansson I; Mkrtchian S; Ingelman-Sundberg M
    J Biol Chem; 1997 Dec; 272(50):31755-63. PubMed ID: 9395520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the region of the aryl hydrocarbon receptor required for ligand dependency of transactivation using chimeric receptor between Drosophila and Mus musculus.
    Kudo K; Takeuchi T; Murakami Y; Ebina M; Kikuchi H
    Biochim Biophys Acta; 2009; 1789(6-8):477-86. PubMed ID: 19560568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dephosphorylation of Sp1 at Ser-59 by protein phosphatase 2A (PP2A) is required for induction of CYP1A1 transcription after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin or omeprazole.
    Shimoyama S; Kasai S; Kahn-Perlès B; Kikuchi H
    Biochim Biophys Acta; 2014 Feb; 1839(2):107-15. PubMed ID: 24382322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of protein tyrosine kinases in CYP1A1 induction by omeprazole and thiabendazole in rat hepatocytes.
    Lemaire G; Delescluse C; Pralavorio M; Ledirac N; Lesca P; Rahmani R
    Life Sci; 2004 Mar; 74(18):2265-78. PubMed ID: 14987951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential ligand-dependent activation and a role for Y322 in aryl hydrocarbon receptor-mediated regulation of gene expression.
    Powis M; Celius T; Matthews J
    Biochem Biophys Res Commun; 2011 Jul; 410(4):859-65. PubMed ID: 21703235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cellular and Molecular Determinants of Naphthoquinone-Dependent Activation of the Aryl Hydrocarbon Receptor.
    Faber SC; Giani Tagliabue S; Bonati L; Denison MS
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32526934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid substitutions in the aryl hydrocarbon receptor ligand binding domain reveal YH439 as an atypical AhR activator.
    Whelan F; Hao N; Furness SG; Whitelaw ML; Chapman-Smith A
    Mol Pharmacol; 2010 Jun; 77(6):1037-46. PubMed ID: 20231332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omeprazole induces NAD(P)H quinone oxidoreductase 1 via aryl hydrocarbon receptor-independent mechanisms: Role of the transcription factor nuclear factor erythroid 2-related factor 2.
    Zhang S; Patel A; Moorthy B; Shivanna B
    Biochem Biophys Res Commun; 2015 Nov; 467(2):282-7. PubMed ID: 26441083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear uptake of the Ah (dioxin) receptor in response to omeprazole: transcriptional activation of the human CYP1A1 gene.
    Quattrochi LC; Tukey RH
    Mol Pharmacol; 1993 Apr; 43(4):504-8. PubMed ID: 8386305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific ligand binding domain residues confer low dioxin responsiveness to AHR1β of Xenopus laevis.
    Odio C; Holzman SA; Denison MS; Fraccalvieri D; Bonati L; Franks DG; Hahn ME; Powell WH
    Biochemistry; 2013 Mar; 52(10):1746-54. PubMed ID: 23394719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico analysis of the interaction of avian aryl hydrocarbon receptors and dioxins to decipher isoform-, ligand-, and species-specific activations.
    Hirano M; Hwang JH; Park HJ; Bak SM; Iwata H; Kim EY
    Environ Sci Technol; 2015 Mar; 49(6):3795-804. PubMed ID: 25692546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of homology models of the AH receptor ligand binding domain: verification of structure-function predictions by site-directed mutagenesis of a nonfunctional receptor.
    Fraccalvieri D; Soshilov AA; Karchner SI; Franks DG; Pandini A; Bonati L; Hahn ME; Denison MS
    Biochemistry; 2013 Jan; 52(4):714-25. PubMed ID: 23286227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for an aryl hydrocarbon receptor-mediated cytochrome p450 autoregulatory pathway.
    Chiaro CR; Patel RD; Marcus CB; Perdew GH
    Mol Pharmacol; 2007 Nov; 72(5):1369-79. PubMed ID: 17720764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone accelerates degradation of aryl hydrocarbon receptor (AHR) and suppresses CYP1A1 induction in placental JEG-3 cell line.
    Stejskalova L; Rulcova A; Vrzal R; Dvorak Z; Pavek P
    Toxicol Lett; 2013 Nov; 223(2):183-91. PubMed ID: 24091107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of aryl hydrocarbon receptor restricts omeprazole-induced chronic kidney disease.
    Sun N; Zhang Y; Ding L; An X; Bai F; Yang Y; Yu K; Fan J; Liu L; Yang H; Yang X
    J Mol Med (Berl); 2024 May; 102(5):679-692. PubMed ID: 38453697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially.
    Ciolino HP; Daschner PJ; Yeh GC
    Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):715-22. PubMed ID: 10359656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the aryl hydrocarbon receptor by the calcium/calmodulin-dependent protein kinase kinase inhibitor 7-oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic acid (STO-609).
    Monteiro P; Gilot D; Langouet S; Fardel O
    Drug Metab Dispos; 2008 Dec; 36(12):2556-63. PubMed ID: 18755850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.